Short answer · Medically reviewed summary · Last updated: 2026-05-08
Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing soft tissue sarcoma primarily affecting the dermis. While it is most commonly referred to as Dermatofibrosarcoma protuberans, it is occasionally identified in older medical literature by historical terms such as Darier-Ferrand disease or progressive recurrent dermatofibroma. Why does Dermatofibrosarcoma protuberans have multiple names? The nomenclature for Dermatofibrosarcoma protuberans has evolved as our understanding of its cellular origin and genetic drivers has improved.
Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing soft tissue sarcoma primarily affecting the dermis. While it is most commonly referred to as Dermatofibrosarcoma protuberans, it is occasionally identified in older medical literature by historical terms such as Darier-Ferrand disease or progressive recurrent dermatofibroma.
The nomenclature for Dermatofibrosarcoma protuberans has evolved as our understanding of its cellular origin and genetic drivers has improved. Historically, it was described by Jean Darier and Marcel Ferrand in 1924, leading to the eponym "Darier-Ferrand disease." As pathology advanced, the term "dermatofibrosarcoma protuberans" became the standard to describe its clinical presentation: a firm, protuberant skin tumor with fibroblastic features. Today, the name reflects the tumor's distinct histology and its tendency to recur locally if not fully excised.
Medical professionals and researchers categorize Dermatofibrosarcoma protuberans using standardized systems to ensure clear communication. The following list details the common identifiers and synonyms you may encounter:
In international medical databases, Dermatofibrosarcoma protuberans is recognized by specific codes that aid in tracking and research. It is classified under Orphanet as ORPHA:228 and is listed in OMIM (Online Mendelian Inheritance in Man) under #607131. In the ICD-10 and ICD-11 coding systems, it is classified as a malignant neoplasm of the skin, highlighting the importance of specialized dermatological and oncological follow-up for the 172 individuals currently sharing their journey within the DiseaseMaps community.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare provider regarding your specific diagnosis and treatment plan.